FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070180862> ?p ?o ?g. }

• W2070180862 endingPage "171" @default.
• W2070180862 startingPage "161" @default.
• W2070180862 abstract "Background: Ribavirin is a broad-spectrum antiviral agent that derives some of its activity from inhibition of cellular inosine monophosphate dehydrogenase (IMPDH), resulting in lower guanosine triphosphate (GTP) levels. Here we report the biological activities of three ribavirin analogues. Methods: Antiviral activities of test compounds were performed by in vitro cytopathic effect inhibition assays against influenza A (H1N1, H3N2 and H5N1), influenza B, measles, parainfluenza type 3 (PIV-3) and respiratory syncytial viruses. Compounds were modelled into the ribavirin 5‘-monophosphate binding site of the crystallographic structure of the human type II IMPDH (hIMPDH2) ternary complex. Effects of compounds on intracellular GTP levels were performed by strong anion exchange HPLC analysis. Results: Of the three compounds evaluated, the 5-ethynyl nucleoside (ETCAR) exhibited virus-inhibitory activities (at 1.2–20 μM, depending upon the virus) against most of the viruses, except for weak activity against PIV-3 (62 μM). Antiviral activity of ETCAR was similar to ribavirin; however, cytotoxicity of ETCAR was greater than ribavirin. Replacing the 5-ethynyl group with a 5-propynyl or bromo substituent (BrCAR) considerably reduced antiviral activity. Computational studies of ternary complexes of hIMPDH2 enzyme with 5‘-monophosphates of the compounds helped rationalize the observed differences in biological activity. All compounds suppressed GTP levels in cells; additionally, BrCAR suppressed adenosine triphosphate and elevated uridine triphosphate levels. Conclusions: Three compounds related to ribavirin inhibited IMPDH and had weak to moderate antiviral activity. Cytotoxicity adversely affected the antiviral selectivity of ETCAR. As with ribavirin, reduction in intracellular GTP may play a role in virus inhibition." @default.
• W2070180862 created "2016-06-24" @default.
• W2070180862 creator A5018500822 @default.
• W2070180862 creator A5043432584 @default.
• W2070180862 creator A5048398642 @default.
• W2070180862 creator A5059015364 @default.
• W2070180862 creator A5074022090 @default.
• W2070180862 creator A5081722728 @default.
• W2070180862 creator A5082996108 @default.
• W2070180862 creator A5085090297 @default.
• W2070180862 creator A5086438008 @default.
• W2070180862 date "2014-08-01" @default.
• W2070180862 modified "2023-10-10" @default.
• W2070180862 title "Antivirally Active Ribavirin Analogues – 4,5-disubstituted 1,2,3-triazole Nucleosides: Biological Evaluation against Certain Respiratory Viruses and Computational Modelling" @default.
• W2070180862 cites W1539101560 @default.
• W2070180862 cites W1967899087 @default.
• W2070180862 cites W1968950430 @default.
• W2070180862 cites W1972000022 @default.
• W2070180862 cites W1975631808 @default.
• W2070180862 cites W1978594581 @default.
• W2070180862 cites W1979381093 @default.
• W2070180862 cites W1982301628 @default.
• W2070180862 cites W1987098640 @default.
• W2070180862 cites W1988077722 @default.
• W2070180862 cites W1988774149 @default.
• W2070180862 cites W1990162272 @default.
• W2070180862 cites W1994227589 @default.
• W2070180862 cites W1997503392 @default.
• W2070180862 cites W2003309895 @default.
• W2070180862 cites W2006369820 @default.
• W2070180862 cites W2007507621 @default.
• W2070180862 cites W2012051375 @default.
• W2070180862 cites W2018140880 @default.
• W2070180862 cites W2018928003 @default.
• W2070180862 cites W2026106960 @default.
• W2070180862 cites W2027868702 @default.
• W2070180862 cites W2037799659 @default.
• W2070180862 cites W2039884199 @default.
• W2070180862 cites W2039930668 @default.
• W2070180862 cites W2040845886 @default.
• W2070180862 cites W2041821890 @default.
• W2070180862 cites W2043580251 @default.
• W2070180862 cites W2046241355 @default.
• W2070180862 cites W2078654359 @default.
• W2070180862 cites W2079066605 @default.
• W2070180862 cites W2084276349 @default.
• W2070180862 cites W2085602220 @default.
• W2070180862 cites W2086477248 @default.
• W2070180862 cites W2098554674 @default.
• W2070180862 cites W2100684650 @default.
• W2070180862 cites W2109666873 @default.
• W2070180862 cites W2120530202 @default.
• W2070180862 cites W2128924487 @default.
• W2070180862 cites W2140284126 @default.
• W2070180862 cites W2147689901 @default.
• W2070180862 cites W2151174475 @default.
• W2070180862 cites W2153918414 @default.
• W2070180862 cites W2156053468 @default.
• W2070180862 cites W2169666280 @default.
• W2070180862 cites W2917237833 @default.
• W2070180862 cites W2951691408 @default.
• W2070180862 cites W2953175249 @default.
• W2070180862 doi "https://doi.org/10.3851/imp2564" @default.
• W2070180862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23538746" @default.
• W2070180862 hasPublicationYear "2014" @default.
• W2070180862 type Work @default.
• W2070180862 sameAs 2070180862 @default.
• W2070180862 citedByCount "37" @default.
• W2070180862 countsByYear W20701808622014 @default.
• W2070180862 countsByYear W20701808622015 @default.
• W2070180862 countsByYear W20701808622016 @default.
• W2070180862 countsByYear W20701808622017 @default.
• W2070180862 countsByYear W20701808622018 @default.
• W2070180862 countsByYear W20701808622019 @default.
• W2070180862 countsByYear W20701808622020 @default.
• W2070180862 countsByYear W20701808622021 @default.
• W2070180862 countsByYear W20701808622022 @default.
• W2070180862 countsByYear W20701808622023 @default.
• W2070180862 crossrefType "journal-article" @default.
• W2070180862 hasAuthorship W2070180862A5018500822 @default.
• W2070180862 hasAuthorship W2070180862A5043432584 @default.
• W2070180862 hasAuthorship W2070180862A5048398642 @default.
• W2070180862 hasAuthorship W2070180862A5059015364 @default.
• W2070180862 hasAuthorship W2070180862A5074022090 @default.
• W2070180862 hasAuthorship W2070180862A5081722728 @default.
• W2070180862 hasAuthorship W2070180862A5082996108 @default.
• W2070180862 hasAuthorship W2070180862A5085090297 @default.
• W2070180862 hasAuthorship W2070180862A5086438008 @default.
• W2070180862 hasBestOaLocation W20701808621 @default.
• W2070180862 hasConcept C109316439 @default.
• W2070180862 hasConcept C116073593 @default.
• W2070180862 hasConcept C118716 @default.
• W2070180862 hasConcept C141071460 @default.
• W2070180862 hasConcept C159047783 @default.
• W2070180862 hasConcept C181199279 @default.
• W2070180862 hasConcept C185592680 @default.
• W2070180862 hasConcept C202751555 @default.
• W2070180862 hasConcept C2522874641 @default.

• next